At Orthobiologics Associates, we follow a meticulous process to determine if peptide therapy is right for you: Your journey begins with an initial consultation where we discuss your health concerns, medical history, and treatment goals
GLP-1 agonist FDA-approved once-weekly 0.252.4 mg Dual GIP/GLP-1 agonist FDA-approved once-weekly 2.515 mg Triple agonist (GLP-1/GIP/glucagon) Phase 3 once-weekly 112 mg Dual GLP-1/glucagon agonist Phase 3 once-weekly trial-reported dosing Amylin analog Phase 3 once-weekly 1.24.5 mg HGH fragment preclinical/community daily 300600 mcg NNMT inhibitor preclinical oral 50-150 mg optional SubQ vial math Oral monoamine reuptake inhibitor trial dosing 0.25-0.5 mg daily Tissue Repair & Recovery Peptides Healing-focused compounds studied for tendon, ligament, muscle, and gut tissue repair
Dermatological and Wound Healing Research Advanced Skin Regeneration and Scar Reduction Research on individual components has shown significant effects on dermal wound healing with enhanced outcomes when anti-inflammatory control is included[14]
Information is for reference only and does not constitute medical advice
Sleep tracking devices can provide objective data on sleep architecture changes, though these consumer devices vary in accuracy
